Amgen Inc (AMGN)
287.87
+7.92
(+2.83%)
USD |
NASDAQ |
Nov 20, 16:00
288.76
+0.89
(+0.31%)
After-Hours: 07:23
Amgen Price: 287.87 for Nov. 20, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 281.10 | 288.48 | 278.56 | 287.87 | 4.230M |
| Nov 19, 2024 | 277.67 | 281.60 | 275.56 | 279.95 | 3.210M |
| Nov 18, 2024 | 279.38 | 281.36 | 276.56 | 278.76 | 3.176M |
| Nov 15, 2024 | 291.50 | 291.50 | 279.62 | 283.61 | 5.325M |
| Nov 14, 2024 | 297.91 | 298.48 | 292.32 | 295.93 | 3.516M |
| Nov 13, 2024 | 306.00 | 307.43 | 298.91 | 301.44 | 3.726M |
| Nov 12, 2024 | 319.59 | 321.22 | 293.80 | 298.84 | 6.680M |
| Nov 11, 2024 | 325.91 | 327.58 | 321.61 | 321.81 | 2.457M |
| Nov 08, 2024 | 322.48 | 328.25 | 321.28 | 325.28 | 1.978M |
| Nov 07, 2024 | 322.00 | 322.97 | 318.54 | 321.91 | 2.655M |
| Nov 06, 2024 | 325.00 | 325.39 | 318.17 | 321.79 | 2.209M |
| Nov 05, 2024 | 316.16 | 319.52 | 313.02 | 319.29 | 1.472M |
| Nov 04, 2024 | 320.58 | 320.58 | 314.61 | 316.91 | 2.090M |
| Nov 01, 2024 | 318.69 | 321.70 | 316.91 | 319.22 | 1.827M |
| Oct 31, 2024 | 317.69 | 323.40 | 315.65 | 320.16 | 2.713M |
| Oct 30, 2024 | 311.95 | 317.90 | 310.63 | 315.54 | 2.224M |
| Oct 29, 2024 | 317.01 | 319.21 | 314.82 | 316.00 | 1.467M |
| Oct 28, 2024 | 318.06 | 320.14 | 315.90 | 317.17 | 1.816M |
| Oct 25, 2024 | 318.49 | 319.20 | 314.88 | 316.98 | 1.605M |
| Oct 24, 2024 | 314.43 | 317.24 | 313.63 | 315.69 | 1.327M |
| Oct 23, 2024 | 316.01 | 318.55 | 313.70 | 314.90 | 1.527M |
| Oct 22, 2024 | 315.24 | 321.08 | 313.98 | 319.66 | 2.107M |
| Oct 21, 2024 | 320.16 | 321.80 | 315.87 | 316.74 | 1.533M |
| Oct 18, 2024 | 320.61 | 322.56 | 319.18 | 321.66 | 1.552M |
| Oct 17, 2024 | 325.92 | 325.92 | 320.50 | 321.33 | 1.636M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
182.24
Minimum
Mar 12 2020
337.38
Maximum
Sep 20 2024
251.54
Average
243.48
Median
Price Benchmarks
| Johnson & Johnson | 153.11 |
| Eli Lilly and Co | 753.41 |
| Merck & Co Inc | 97.44 |
| Regeneron Pharmaceuticals Inc | 743.35 |
| Viking Therapeutics Inc | 51.53 |
Price Related Metrics
| PE Ratio | 36.86 |
| PS Ratio | 4.771 |
| Price to Book Value | 20.56 |
| Price to Free Cash Flow | 24.71 |
| Earnings Yield | 2.71% |
| Market Cap | 154.74B |
| Operating PE Ratio | 24.97 |
| Normalized PE Ratio | 36.86 |